Clinical Trial Update: Colistin Intravenous Administration in Critically Ill Patients Suffering From Hospital Infections Caused by Multi-antibiotic-resistant Germs. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating intravenous colistin for hospitalized, critically ill patients with infections caused by multi-antibiotic–resistant organism…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hospital-acquired Infection
• Multi-drug Resistant Infection

Drugs mentioned

• Colistin (colistin)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Hospital Infection, Multi-antibiotic Resistance | Phase 4 | Status: UNKNOWN